4 Marijuana Stocks to Buy After Earnings Report?

4 Marijuana Stocks For Your 2022 Watchlist

Some marijuana stocks are slowly building good momentum. Much of this can be attributed to positive speculation as shareholders wait for earnings to fall. This month several leading cannabis companies are set to release earnings that are said to be solid reports for many. The growth of the cannabis industry is unmatched by few other industries. This growth comes from companies expanding whether through M&A or opening new facilities. More places around the world especially the United States are pushing for better cannabis laws.

Until now in 2022 many states are preparing to vote on the legalization of cannabis. If successful this will only add more value to the cannabis industry and possibly help see some upward selling for some marijuana stocks. If you are looking at the sector and you see it is trading quickly you know if you are looking to invest time is key. You’ll want to wait for this volatile trade to show some pullback before looking for marijuana stocks to buy.

You always want to wait for a drop before buying or if you feel that the stock will rise in the near future from the current price. Buying low and selling high is always the key strategy for any type of investment. Just make sure you do your research and learn all you can about the cannabis stocks that interest you. Knowing about a company’s current financials and projects can give you a good idea of ​​when money is being made and whether the company is heading in the right direction. The companies mentioned below are great marijuana stocks to watch right now.

Top Marijuana Stocks To Watch In The Stock Market Today

1. Green Thumb Industries Inc. (OTC:GTBIF)
2. Trulieve Cannabis Corp. (OTC:TCNNF)
3. Curaleaf Holdings, Inc. (OTC:CURLF)
4. Cresco Labs Inc. (OTC:CRLBF)
5. Greenlane Holdings, Inc. (NASDAQ:GNLN)

Green Thumb Industries Inc.

Green Thumb Industries Inc. engages in the manufacture, distribution, and sale of various cannabis products for medical and adult use in the United States. On August 3 the company released its second quarter 2022 earnings.

Q2 2022 Highlights

• Revenue increased 4.8% sequentially and 14.6% year-over-year to $254.3 million.
• First half 2022 revenue increased 19.4% to $496.9 million compared to the first half of 2021.
• An eighth consecutive quarter of positive GAAP net income, delivering $24.4 million or $0.11 per basic and $0.10 per diluted share.
• Adjusted Operating EBITDA grew 17.4% sequentially to $78.7 million or 31.0% of revenue.
• Cash flow from operations was $39.9 million year to date.

Words From The Company

“We are pleased with our second quarter results, especially in this challenging economic environment. Five percent revenue growth and more than 300 basis points improvement in adjusted EBITDA margins last quarter shows the results of our focus. We continue to maintain a strong balance sheet, which gives us enough flexibility to support our growth initiatives,” said Green Thumb Founder, Chairman, and Chief Executive Officer Ben Kovler.

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. together with its subsidiaries operates as a medical cannabis company. It cultivates and manufactures the products in-house and distributes its products to Trulieve branded stores throughout the United States. In recent news, the company once again reported record earnings. The company released there Q2 2022 earnings on August 10th.

Main Discussions And Notes

• Revenue rose 49% year over year to $320.3 million from $215.1 million and 1% sequentially.
• Retail revenue increased 3% to $298.6 million and wholesale, licensing and other revenue decreased 22% sequentially to $21.7 million.
• Gross profit of $182.2 million and GAAP gross margin of 57% in the second quarter compared to gross profit of $178.2 million and GAAP gross margin of 56% in the first quarter of 2022.
• Adjusted EBITDA grew 17% year over year to $111.0 million*, or 35% of revenue in the second quarter compared to Adjusted EBITDA of $105.5 million*, or 33% of revenue in the first quarter of 2022.
• Cash at quarter end of $181.4 million.

Words From the CEO

“Our team delivered strong results in the second quarter with topline growth and margin improvement by staying focused on our plan,” said Kim Rivers, Trulieve CEO. “During our mid-year strategic review, we identified proactive measures to address the rapidly evolving economic landscape.”

[Read More] Top Marijuana Penny Stocks To Watch For Q3 2022

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. operates as a cannabis operator in the United States. It operates in two segments, Cannabis Operations, and Non-Cannabis Operations. On August 8th, the company released its latest earnings report.

Second Quarter 2022 Highlights

• Second Quarter 2022 Revenue of $338 Million, an increase of 8% sequentially and YoY
• Second Quarter 2022 Adjusted EBITDA(1) of $86 Million, an increase of 18% sequentially and 2% YoY
• Generated $12 Million in Positive Operating Cash Flow for the First Half of 2022
• Added seven new retail dispensaries, closing the quarter with 135 total locations, and serving nearly 2,200 wholesale partner accounts.
• Adult-use sales began in New Jersey, which BDSA estimates will be a $2.3 billion market by 2026.
• Implemented historic 4/20 with net income increasing 45% year-over-year.

Matt Darin, Chief Executive Officer of Curaleaf, stated, “In the second quarter we made significant changes and some bold decisions to focus on operational excellence, innovative products and brands, and leadership talent. , and we are already seeing positive results as demonstrated by a 267 bps improvement in gross margin on cannabis sales. This quarter we continued to grow our retail footprint, expand our distribution partnerships, and launch the new product lines that will inspire consumers and revitalize the industry.

[Read More] Top Marijuana Stocks That Moved This Week

Cresco Labs Inc.

Cresco Labs Inc. together with its subsidiaries cultivates, manufactures, and markets retail and medical cannabis products in the United States. The company recently announced that Illinois has begun issuing new dispensary use licenses to adults. Who Cresco is considering getting one. Also, the company announced that it will release its earnings on August 16th.

Words From Charlie Bachtell

“We’re excited for all of the new cannabis business owners in Illinois to finally have a chance to get their businesses up and running. We’re also very proud of our members at Cresco Labs who—through our SEED Community Business Incubator—helps social equity groups with their license applications,” said Charlie Bachtell, CEO, and Co-Founder of Cresco Labs.

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. develops and distributes cannabis accessories, child-resistant packaging, vape solutions, and lifestyle products in the United States, Canada, and Europe. It operates through two segments, Consumer Goods and Industrial Goods. In recent news, the company announced that it has acquired a $15 million asset-based loan. The loan is for a term of three years and will support Greenlane’s strategic initiatives and working capital requirements.

“We continue to make solid progress on our previously announced strategic plan to reduce our cost structure, accelerate our path to profitability, and increase liquidity on a non-dilutive basis,” it said. Nick Kovacevich, CEO of Greenlane.